BackgroundCheck.run
Search For

Kevin J Quackenbush, 5336 Osage Ln, Groton, CT 06340

Known as:
Kev Quackenbush Kevin Quakenbush Kevin Quckenbush Blake Gunderman Mark Stuhl
Related to:
Dora A Meyer 67

Kevin Quackenbush Phones & Addresses

36 Osage Ln, Groton, CT 06340    860-5364911   

82 South Rd, Groton, CT 06340    860-4462378    860-9225807   

Gales Ferry, CT   

Tonalea, AZ   

Stonington, CT   

Athens, OH   

Get Report
Control this profile

Mentions for Kevin J Quackenbush

Kevin Quackenbush resumes & CV records

Resumes

Kevin Quackenbush Photo 44

Temple University Graduate School

Location:
36 Osage Ln, Groton, CT 06340
Industry:
Biotechnology
Work:

Temple University Graduate School
Education:
Southern Connecticut State University 1989 - 1993
Bachelors, Biology Ledyard High School
Temple University
Master of Science, Masters, Pharmacy
Skills:
Leadership, Business Strategy, Management, Microsoft Office, Project Management, Product Development, Business Development, Cross Functional Team Leadership, Healthcare, Strategy
Languages:
French
Kevin Quackenbush Photo 45

Kevin Quackenbush

Kevin Quackenbush Photo 46

Kevin Quackenbush

Publications & IP owners

Wikipedia

Kevin Quackenbush Photo 55

Kevin Quackenbush

Kevin Robert Quackenbush (born November 28, 1988) is an American professional baseball pitcher for the San Diego Padres of Major League Baseball (MLB).

Us Patents

Novel Forms Of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoicacid Calcium Salt (2:1)

US Patent:
2008030, Dec 11, 2008
Filed:
Jul 11, 2005
Appl. No.:
11/572333
Inventors:
Joseph F. Krzyzaniak - Pawcatuck CT, US
George M. Laurence - Lawrence KS, US
Aeri Park - West Lafayette IN, US
Kevin J. Quackenbush - Noank CT, US
Marie L. Reynolds - Lebanon CT, US
Peter R. Rose - Ledyard CT, US
Timothy A. Woods - Remington IN, US
International Classification:
C07D 207/34
US Classification:
548537
Abstract:
Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease.

Novel Forms Of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta,Delta-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylmino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)

US Patent:
2011030, Dec 8, 2011
Filed:
Aug 22, 2011
Appl. No.:
13/214559
Inventors:
Joseph F. Krzyzaniak - Pawcatuck CT, US
George M. Laurence - Lawrence KS, US
Aeri Park - West Lafayette IN, US
Kevin J. Quackenbush - Groton CT, US
Marie L. Reynolds - Lebanon CT, US
Peter R. Rose - Ledyard CT, US
Timothy A. Woods - Remington IN, US
Assignee:
Pfizer Inc. - New York NY
International Classification:
C07D 207/34
US Classification:
548537
Abstract:
Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXVV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPII) and Alzheimer's disease.

Novel Forms Of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)

US Patent:
2014001, Jan 16, 2014
Filed:
Sep 9, 2013
Appl. No.:
14/021151
Inventors:
George Michael Laurence - Laurence KS, US
Aeri Park - Lansdale PA, US
Kevin Quackenbush - Groton CT, US
Marie Louise Reynolds - Lebanon CT, US
Peter Robert Rose - Ledyard CT, US
Timothy Andrew Woods - Edinburgh IN, US
Assignee:
Warner-Lambert Company LLC - New York NY
International Classification:
C07D 207/34
US Classification:
548537
Abstract:
Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease.

Novel Forms Of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)

US Patent:
2018000, Jan 11, 2018
Filed:
Sep 11, 2017
Appl. No.:
15/700734
Inventors:
- New York NY, US
George Michael Laurence - West Lafayette IN, US
Aeri Park - Lansdale PA, US
Kevin Quackenbush - Groton CT, US
Marie Louise Reynolds - Lebanon CT, US
Peter Robert Rose - Ledyard CT, US
Timothy Andrew Woods - Edinburgh IN, US
International Classification:
C07D 207/34
Abstract:
Novel forms of [R-(R*,R*)]--(-fluorophenyl)-β,δ-dihydroxy--(-methylethyl)--phenyl--[(phenylamino)carbonyl]-H-pyrrole--heptatonic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease.

Novel Forms Of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)

US Patent:
2017002, Jan 26, 2017
Filed:
Oct 4, 2016
Appl. No.:
15/285037
Inventors:
- New York NY, US
George Michael Laurence - West Lafayette IN, US
Aeri Park - Lansdale PA, US
Kevin Quackenbush - Groton CT, US
Marie Louise Reynolds - Lebanon CT, US
Peter Robert Rose - Ledyard CT, US
Timothy Andrew Woods - Edinburgh IN, US
International Classification:
C07D 207/34
Abstract:
Novel forms of [R, (R*,R*)]--(-Fluorophenyl)-β,δdihydroxy--methylethyl)--phenyl--[(phenylamino)carbonyl]--H-pyrrole--heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Forms XXV, Form XXVII, Form XXVIII, Form XXXIX, and Forms XXX, characterized by their X-ray powder diffractor, solid state NMR, and/or Raman spectroscopy are describes as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer) disease.

Novel Forms Of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)

US Patent:
2016004, Feb 18, 2016
Filed:
Oct 27, 2015
Appl. No.:
14/924011
Inventors:
- New York NY, US
George Michael Laurence - West Lafayette IN, US
Aeri Park - Lansdale PA, US
Kevin Quackenbush - Groton CT, US
Marie Louise Reynolds - Lebanon CT, US
Peter Robert Rose - Ledyard CT, US
Timothy Andrew Woods - Edinburgh IN, US
International Classification:
C07D 207/34
Abstract:
Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease.

Novel Forms Of [R-(R*,R*)]-2-(4-Fluorophenyl)-Beta, Gamma-Dihydroxy-5-(1-Methylethyl)-3-Phenyl-4-[(Phenylamino)Carbonyl]-1H-Pyrrole-1-Heptanoic Acid Calcium Salt (2:1)

US Patent:
2015004, Feb 12, 2015
Filed:
Oct 22, 2014
Appl. No.:
14/520742
Inventors:
- New York NY, US
George Michael Laurence - Laurence KS, US
Aeri Park - Lansdale PA, US
Kevin Quackenbush - Groton CT, US
Marie Louise Reynolds - Lebanon CT, US
Peter Robert Rose - Ledyard CT, US
Timothy Andrew Woods - Edinburgh IN, US
International Classification:
C07D 207/34
US Classification:
548537
Abstract:
Novel forms of [R—(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt designated Form XX, Form XXI, Form XXII, Form XXIII, Form XXIV, Form XXV, Form XXVI, Form XXVII, Form XXVIII, Form XXIX, and Form XXX, characterized by their X-ray powder diffraction, solid-state NMR, and/or Raman spectroscopy are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as agents for treating hyperlipidemia, hypercholesterolemia, osteoporosis, benign prostatic hyperplasia (BPH) and Alzheimer's disease.

Amazon

Kevin Quackenbush Photo 56

Your Credit Has Been Comprimised. The Collection Agencies Are Coming After You. Help! Now What Do I Do??? By Michael E. Friedman Ph.d. Kevin Quackenbush M.s. (2014-05-03)

Author:
Michael E. Friedman Ph.D. Kevin Quackenbush M.S.
Publisher:
KJQ LLC
Binding:
Paperback
Kevin Quackenbush Photo 57

Chikara Yearbook-2011 Edition

Author:
Mike Quackenbush, Kevin Ford
Publisher:
Mike Quackenbush, Kevin Ford
Binding:
Kindle Edition
Pages:
259
Description: CHIKARA - It's the Japanese word for "power." But to fans of independent pro-wrestling, it means a whole lot more. CHIKARA means unique characters, original concepts, cutting edge wrestling and an off-the-wall sense of humor. Now, armed with this 2011 update, you can jump head-first int...
Kevin Quackenbush Photo 58

Your Credit Has Been Comprimised. The Collection Agencies Are Coming After You. Help! Now What Do I Do???

Author:
Michael E. Friedman Ph.D. Kevin Quackenbush M.S.
Publisher:
KJQ LLC
Binding:
Paperback
Pages:
99
ISBN #:
1630685860
EAN Code:
9781630685867
This is a book/guide for those who's credit has been compromised! This step by step book will help you LEGALLY STOP COLLECTION AGENCIES and/or creditors (i.e. banks...) FROM COMING AFTER YOU and how to begin to restore your credit.
Kevin Quackenbush Photo 59

Conductivity Sensing Ensures Consistent Rubber Product Quality While Reducing Costs.(Process Machinery): An Article From: Rubber World

Author:
J. Kevin Quackenbush
Publisher:
Thomson Gale
Binding:
Digital
Pages:
3
This digital document is an article from Rubber World, published by Thomson Gale on August 1, 2006. The length of the article is 704 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker imme...

Possible Relatives

Cynthia A Quackenbush  David C Quackenbush  Dawn M Quackenbush  Dean T Quackenbush  Daniel F Quackenbush  Aaron M Quackenbush  Denise A Quackenbush  Kevin T Johnson  Kevin Stamps  Kevin Stanberry 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.